Defective Cytochrome P450-Catalysed Drug Metabolism in Niemann-Pick Type C Disease.
Niemann-Pick type C (NPC) disease is a neurodegenerative lysosomal storage disease caused by mutations in either the NPC1 or NPC2 gene. NPC is characterised by storage of multiple lipids in the late endosomal/lysosomal compartment, resulting in cellular and organ system dysfunction. The underlying m...
Main Authors: | Elena-Raluca Nicoli, Nada Al Eisa, Celine V M Cluzeau, Christopher A Wassif, James Gray, Kathryn R Burkert, David A Smith, Lauren Morris, Stephanie M Cologna, Cody J Peer, Tristan M Sissung, Constantin-Daniel Uscatu, William D Figg, William J Pavan, Charles H Vite, Forbes D Porter, Frances M Platt |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4809520?pdf=render |
Similar Items
-
Modeling Niemann-Pick disease type C1 in zebrafish: a robust platform for in vivo screening of candidate therapeutic compounds
by: Wei-Chia Tseng, et al.
Published: (2018-09-01) -
Quantitative proteomic analysis of Niemann-Pick disease, type C1 cerebellum identifies protein biomarkers and provides pathological insight.
by: Stephanie M Cologna, et al.
Published: (2012-01-01) -
Abnormal LAMP1 glycosylation may play a role in Niemann-Pick disease, type C pathology.
by: Niamh X Cawley, et al.
Published: (2020-01-01) -
Identification of Novel Pathways Associated with Patterned Cerebellar Purkinje Neuron Degeneration in Niemann-Pick Disease, Type C1
by: Kyle B. Martin, et al.
Published: (2019-12-01) -
Characterization of hydroxypropyl-beta-cyclodextrins used in the treatment of Niemann-Pick Disease type C1.
by: Alfred L Yergey, et al.
Published: (2017-01-01)